dermatosis

(redirected from dermopathy)
Also found in: Dictionary, Thesaurus, Medical, Wikipedia.

dermatosis

[‚dər·mə′tō·səs]
(medicine)
Any skin disease.
References in periodicals archive ?
Cutaneous manifestations such as diabetic dermopathy, necrobiosis lipoidica diabeticorum, syndromes of limited joint mobility are extremely important to the clinician as they are indicators of underlying chronic degenerative complications such as retinopathy, neuropathy and nephropathy and hence an "alarm bell to alert the physician".
Diabetic dermopathy is found in 30% - 60% of patients and is the most common finding in diabetics.
The presence of acropathy shows the severity of ophthalmopathy and dermopathy.
According to the International Center for Nephrogenic Fibrosing Dermopathy Research (ICNFDR), patients with NFD/NSF experience swelling and tightening of the skin with induration usually involving the distal extremities, but sometimes involving the trunk (Cowper, 2008).
Autosomal dominant dilated cardiomyopathy with conduction system disease * Autosomal dominant and recessive Emery Dreifuss Muscular Dystrophy * Limb girdle muscular dystrophy type 1B with atrioventricular conduction disturbances * Autosomal recessive type 2 Charcot Marie Tooth * Mandibuloacral dysplasia * Dunnigan-type familial partial lypodystrophy * Generalized lipoatrophy, insulin-resistant diabetes, leukomelanodermic papules, liver steatosis and cardiomyopathy * Hutchinson-Gilford progeria syndrome * Atypical Werner syndrome * Restrictive Dermopathy
Nephrogenic fibrosing dermopathy (NFD) causes thickening and hardening of the skin, often in the extremities, and occurs in patients with underlying renal disease.
Gadolinium-based contrast agents, when given to patients with renal disease, have been associated with a rare, potentially fatal, sclerodermalike skin disease called nephrogenic systemic fibrosis or nephrogenic fibrosing dermopathy.
Gadolinium-based contrast agents, when given to patients with renal disease, have been associated with a rare, potentially fatal, scleroderma-like skin disease called nephrogenic systemic fibrosis or nephrogenic fibrosing dermopathy.
The Web site address is the acronym for the International Center for Nephrogenic Fibrosing Dermopathy Research.
Experienced dermatologists diagnosed arsenic dermopathy based on the features discussed in our previous publications (5).
A small study presented at the annual meeting of the American Association of Clinical Endocrinologists found that 31 of 39 patients with acropachy (79%) and 81 of 102 patients with dermopathy (79%) had a history of smoking.